am i eligible for glp 1 GLP-1 Medications Infographic GLP-1 Drugs for Weight Loss:
Description
Multidisciplinary support remains essential regardless of funding route, incorporating dietetic input, psychological support, and ongoing medical monitoring to optimise outcomes

[4] Whilst these incretin-based therapies offer significant metabolic benefits, they commonly affect gastrointestinal function, including bowel movements
Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure

P2P review overturns denials about 35-45% of the time when the prescriber comes prepared with chart data and trial evidence
It also supports metabolic health by improving how your body handles fat storage and insulin sensitivity